Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2008 2
2009 1
2010 2
2011 2
2012 6
2013 3
2014 2
2015 3
2017 1
2018 1
2019 2
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Kappos L, Radue EW, Comi G, Montalban X, Butzkueven H, Wiendl H, Giovannoni G, Hartung HP, Derfuss T, Naegelin Y, Sprenger T, Mueller-Lenke N, Griffiths S, von Rosenstiel P, Gottschalk R, Zhang Y, Dahlke F, Tomic D; TOFINGO study group. Kappos L, et al. Among authors: mueller lenke n. Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29. Neurology. 2015. PMID: 26024899 Free PMC article.
Multivariate pattern classification of gray matter pathology in multiple sclerosis.
Bendfeldt K, Klöppel S, Nichols TE, Smieskova R, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Radue EW, Borgwardt SJ. Bendfeldt K, et al. Among authors: mueller lenke n. Neuroimage. 2012 Mar;60(1):400-8. doi: 10.1016/j.neuroimage.2011.12.070. Epub 2012 Jan 5. Neuroimage. 2012. PMID: 22245259
No influence of KIF1B on neurodegenerative markers in multiple sclerosis.
Sombekke MH, Jafari N, Bendfeldt K, Mueller-Lenke N, Radue EW, Naegelin Y, Kappos L, Matthews PM, Polman CH, Barkhof F, Hintzen R, Geurts JJ. Sombekke MH, et al. Among authors: mueller lenke n. Neurology. 2011 May 24;76(21):1843-5. doi: 10.1212/WNL.0b013e31821cccd4. Neurology. 2011. PMID: 21606458 No abstract available.
Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study.
Bendfeldt K, Egger H, Nichols TE, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Radue EW, Borgwardt SJ. Bendfeldt K, et al. Among authors: mueller lenke n. Brain Res. 2010 Apr 14;1325:174-82. doi: 10.1016/j.brainres.2010.02.035. Epub 2010 Feb 16. Brain Res. 2010. PMID: 20167205
22 results